Based on the measurements of operating efficiency obtained from Kezar Life's historical financial statements, Kezar Life Sciences may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. At this time, Kezar Life's Other Assets are relatively stable compared to the past year. As of 02/27/2025, Net Receivables is likely to grow to about 2.8 M, while Total Stockholder Equity is likely to drop slightly above 129.1 M. Key indicators impacting Kezar Life's financial strength include:
The financial analysis of Kezar Life is a critical element in measuring its lifeblood. Investors should not minimize Kezar Life's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Kezar Life competes with Century Therapeutics, Mineralys Therapeutics,, Nkarta, Surrozen, and Bolt Biotherapeutics. Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company was incorporated in 2015 and is based in South San Francisco, California. Kezar Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 56 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
The reason investors look at the income statement is to determine what Kezar Life's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Kezar Life's current stock value. Our valuation model uses many indicators to compare Kezar Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kezar Life competition to find correlations between indicators driving Kezar Life's intrinsic value. More Info.
Kezar Life Sciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Kezar Life's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Kezar Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Kezar Life Sciences Systematic Risk
Kezar Life's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Kezar Life volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Kezar Life Sciences correlated with the market. If Beta is less than 0 Kezar Life generally moves in the opposite direction as compared to the market. If Kezar Life Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Kezar Life Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Kezar Life is generally in the same direction as the market. If Beta > 1 Kezar Life moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Kezar Life Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Kezar Life's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Kezar Life growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Kezar Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kezar Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kezar Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Kezar Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kezar Life's daily price indicators and compare them against related drivers.
When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.